Andrew Mannes, M.D., M.E.
Department of Perioperative Medicine
NIH Clinical Center
Building 10, Room 2C744
10 Center Drive
Bethesda, MD 20814
Dr. Andrew Mannes is chief of the Clinical Center's Department of Perioperative Medicine. Dr. Mannes has a long-standing interest in the treatment of severe pain often seen at the end of life. His current interests include developing pain therapies using gene therapy; targeting pain pathways with selective agonists, toxins, or fusion proteins; and improving the diagnosis of disease states using proteomic and genomic techniques.
Dr. Mannes has written widely in books and medical journals on such topics as advances in cancer pain management, gene therapy for pain, and neurosurgical intervention approaches to pain relief. He is board certified in anesthesiology and fellowship-trained in pain management. He collaborates with the Clinical Center's Pain and Palliative Care Service in the area of pain management and has also worked on treatment of chronic pain with investigators in the laboratories of the Pain and Neurosensory Mechanisms Branch of the National Institute of Dental and Craniofacial Research.
Following completion of a Bachelor of Science degree in Bio-Engineering at the University of Pennsylvania and a Master of Engineering degree at Dartmouth College, Dr. Mannes received his MD degree at George Washington University. He completed a transitional internship at the Presbyterian Hospital of Philadelphia followed by an anesthesia residency at the Hospital of the University of Pennsylvania. While at University of Pennsylvania, he completed a fellowship in pain management and joined the Penn faculty as an Instructor in Anesthesiology in 1994. He was promoted to Assistant Professor of Anesthesiology in 1997 before coming to NIH. Dr. Mannes completed an NIH research fellowship in molecular biology in 1997. He has been in the Department of Anesthesia and Surgical Services since 2001.
Dr. Mannes is a member of the American Medical Association and is on the editorial advisory board of Open Pain Journal.
LaPaglia DM, Sapio MR, Burbelo PD, Thierry-Mieg J, Thierry-Mieg D, Raithel SJ, Ramsden CE, Iadarola MJ, Mannes AJ. RNA-Seq investigations of human post-mortem trigeminal ganglia. Cephalalgia. 2018;38(5):912-932.
Iadarola MJ, Sapio MR, Wang X, Carrero H, Virata-Theimer ML, Sarnovsky R, Mannes AJ, FitzGerald DJ. Analgesia by Deletion of Spinal Neurokinin 1 Receptor Expressing Neurons Using a Bioengineered Substance P-Pseudomonas Exotoxin Conjugate. Mol Pain. 2017;13:1744806917727657.
Sapio MR, Goswami SC, Gross JR, Mannes AJ, Iadarola MJ. Transcriptomic analyses of genes and tissues in inherited sensory neuropathies. Exp Neurol. 2016;283(Pt A):375-395.
Iadarola MJ, Sapio MR, Mannes AJ. A new splice of life for the μ-opioid receptor. J Clin Invest. 2015;125(7):2558-61.
Iadarola MJ, Mannes AJ. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem. 2011;11(17):2171-9.
Related Scientific Focus Areas
Molecular Biology and Biochemistry
This page was last updated on November 20th, 2018